A. To lobby for improved industry standards for the development of new safe, effective, and high-quality
medicines for the ICH regions

B. To provide scientific evaluation of applications for international marketing authorization for safe,
effective, and high-quality medicines for the ICH regions

C. To discuss and establish common guidelines for safe, effective, and high-quality medicines for the ICH
regions

D. To protect and promote public health through the evaluation and supervision of safe, effective, and
high-quality medicines for the ICH regions